HPV immunization in cervical cancer prevention


The latest research has provided a unique opportunity to be immunized against a HPV (human papillomavirus) infection, which, in 80% of the cases, is responsible for the occurrence of changes on the cervix, which after a few years may lead to the development of cervical cancer.

HPV is a sexually transmitted infection. Most carriers of the virus are asymptomatic and, therefore, can easily spread the infection.

Femina-Med has for many years successfully used Silgard – a vaccine in the form of suspension for injection in a pre-filled syringe. It immunized against human papillomavirus [types 6, 11, 16, 18] (recombinant, adsorbed).

The HPV vaccine is injected in the deltoid muscle, three times over six months – the second injection is two months after the first, and the third injection is six months after the first shot was administered. It is painless and does not require any special preparation of the patient.